Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис:
http://hdl.handle.net/20.500.12188/9671| Наслов: | Efficacy and safety of levofloxacin in the outpatient treatment of exacerbation of chronic obstructive pulmonary disease: levofloxacin 750 mg vs. levofloxacin 500 mg | Authors: | Minov, J Stoleski, S Petrova, T Vasilevska, K Mijakoski, D Karadzinska-Bislimovska, J |
Keywords: | bacterial exacerbation chronic obstructive pulmonary disease clinical success rate levofloxacin relaps side effects |
Issue Date: | 2020 | Publisher: | Open Access Text Pvt, Ltd. | Journal: | Health and Primary Care | URI: | http://hdl.handle.net/20.500.12188/9671 | DOI: | 10.15761/hpc.1000184 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Files in This Item:
| File | Опис | Size | Format | |
|---|---|---|---|---|
| Efficacy and safety of levofloxacin in the outpatient treatment of exacerbation of COPD levofloxacin 750 vs 500 mg_HPC-4-184.pdf | 331.14 kB | Adobe PDF | View/Open |
Page view(s)
100
checked on 24.7.2024
Download(s)
113
checked on 24.7.2024
Google ScholarTM
Проверете
Altmetric
Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.